Pharma Journalist -

Melinta Therapeutics, LLC and Cidara Therapeutics announced that they have entered into a License Agreement to facilitate a strategic partnership to commercialize rezafungin, a novel,…
Read More...

Novavax, Inc. announced that Nuvaxovid COVID-19 vaccine received expanded manufacturing and marketing approval from the Japan Ministry of Health, Labour and Welfare (MHLW) for primary…
Read More...

AbbVie announced the European Commission (EC) approved RINVOQ (upadacitinib 45 mg and 15 mg and 30 mg ) for the treatment of adult patients with moderately to severely active…
Read More...

Ionis Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) for tofersen, an investigational antisense medicine for the…
Read More...

AstraZeneca and Daiichi Sankyo have received notification of acceptance of the supplemental Biologics License Application (sBLA) of Enhertu (trastuzumab deruxtecan) for the treatment of…
Read More...

Bavarian Nordic A/S announced that the European Commission (EC) has extended the marketing authorization for the Company’s smallpox vaccine, IMVANEX to include protection from monkeypox…
Read More...

Sandoz announced that the US Food and Drug Administration (FDA) has accepted its biologics license application (BLA) for a proposed first-of-a-kind biosimilar natalizumab, developed by…
Read More...

Today, Ginkgo Bioworks — the leading horizontal platform for cell programming — and the biotechnology company Zymergen announced they have entered into a definitive agreement under…
Read More...

NewAmsterdam Pharma Holding B.V. a late clinical-stage company focused on the research and development of transformative oral therapies for major cardiometabolic diseases, and Frazier…
Read More...

Sangamo Therapeutics, Inc. announced that the European Commission (EC) has granted Orphan Medicinal Product Designation (OMPD) to TX200, a wholly-owned autologous Chimeric Antigen…
Read More...